Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 43 Breast Neoplasms 31 Prostatic Neoplasms 27 Colorectal Neoplasms 26 Lung Neoplasms 17 Hematopoietic and Lymphatic System Neoplasm 12 Ovarian Neoplasms 11 Hematologic Neoplasms 11 Uterine Cervical Neoplasms 7 Multiple Myeloma 7 Lymphoma 7 Leukemia 7 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Depression 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Pancreatic Neoplasms 5 Leukemia, Myeloid, Acute 5 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4 Mouth Neoplasms 4 Motor Activity 4 Melanoma 4 Hematopoietic and Lymphoid System Neoplasm 4 Gastrointestinal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Anxiety Disorders 4 Advanced Cancer 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3

Interventions

Paclitaxel 7 Doxorubicin 5 pembrolizumab 4 pazopanib 4 Gemcitabine 4 Bevacizumab 4 durvalumab 3 Radiotherapy 3 Propranolol 3 Docetaxel 3 regorafenib 2 cemiplimab 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Nivolumab 2 Ifosfamide 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 tremelimumab 1 trebananib 1 trastuzumab duocarmazine 1 talimogene laherparepvec 1 talazoparib 1 spartalizumab 1 sintilimab 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemangiosarcoma × Interviews as Topic × Clear all

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡